We are live on !
Find out more
UBS Portfolio holdings
AUM
$136B
Turnover
18.95%
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$3.56B
Cap. Flow % of AUM
Cap. Flow %
2.62%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.72% |
| 2 | Energy | 9.22% |
| 3 | Financials | 6.8% |
| 4 | Healthcare | 6.74% |
| 5 | Technology | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5326
Arrow Financial
AROW
$716M
| $172K | ﹤0.01% |
8,859
-4,100
| -32% | -$81.1K |
2013 Q2
5 quarters
|
|
5327
PUT
Clorox
CLX
$10.7B
| $172K | ﹤0.01% |
1,800
+300
| +20% | +$27.1K |
2013 Q2
5 quarters
|
|
5328
CALL
Dorman Products
DORM
$3.92B
| $172K | ﹤0.01% |
4,300
+4,000
| +1,333% | +$179K |
2014 Q2
1 quarter
|
|
5329
PUT
ProShares UltraShort Euro
EUO
$45.6M
| $172K | ﹤0.01% |
8,600
+8,200
| +2,050% | +$149K |
2013 Q2
5 quarters
|
|
5330
Globalstar
GSAT
$10.8B
| $172K | ﹤0.01% |
3,123
+927
| +42% | +$55.3K |
2014 Q2
1 quarter
|
|
5331
PUT
Neurocrine Biosciences
NBIX
$14.9B
| $172K | ﹤0.01% |
11,000
+10,000
| +1,000% | +$149K |
2014 Q1
2 quarters
|
|
5332
Pegasystems
PEGA
$5.54B
| $172K | ﹤0.01% |
18,000
+804
| +5% | +$8.68K |
2013 Q2
5 quarters
|
|
|
BBG
5333
CALL
DELISTED
Bill Barrett Corp
BBG
| $172K | ﹤0.01% |
7,800
-64,800
| -89% | -$1.51M |
2014 Q1
2 quarters
|
|
5334
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
| $172K | ﹤0.01% |
17,400
+100
| +0.6% | +$1.48K |
2013 Q2
5 quarters
|
|
5335
Comtech Telecommunications
CMTL
$39.8M
| $171K | ﹤0.01% |
4,592
-7,220
| -61% | -$264K |
2013 Q2
5 quarters
|
|
|
RAI
5336
CALL
DELISTED
Reynolds American Inc
RAI
| $171K | ﹤0.01% |
5,800
+4,000
| +222% | +$116K |
2013 Q2
5 quarters
|
|
|
SQNM
5337
DELISTED
SEQUENOM INC NEW
SQNM
| $171K | ﹤0.01% |
57,557
-40,617
| -41% | -$149K |
2013 Q2
5 quarters
|
|
5338
Commercial Metals
CMC
$7.28B
| $170K | ﹤0.01% |
9,948
-1,379
| -12% | -$24.2K |
2013 Q2
5 quarters
|
|
5339
CALL
Gerdau
GGB
$9.32B
| $170K | ﹤0.01% |
44,730
-19,656
| -31% | -$89.9K |
2013 Q2
5 quarters
|
|
5340
CALL
ProShares Short S&P500
SH
$924M
| $170K | ﹤0.01% |
925
-475
| -34% | -$87.7K |
2013 Q2
5 quarters
|
|
|
REDF
5341
DELISTED
REDIFF.COM INDIA LTD ADS
REDF
| $170K | ﹤0.01% |
74,487
-668
| -0.9% | -$1.66K |
2013 Q2
5 quarters
|
|
|
NCFT
5342
DELISTED
NORCRAFT COS INC COM STK (DE)
NCFT
| $170K | ﹤0.01% |
10,643
+7,740
| +267% | +$117K |
2013 Q4
3 quarters
|
|
|
CPWR
5343
PUT
DELISTED
COMPUWARE CORP
CPWR
| $170K | ﹤0.01% |
16,656
+15,615
| +1,500% | +$147K |
2014 Q2
1 quarter
|
|
5344
DELISTED
IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN
XXV
| $170K | ﹤0.01% |
4,430
-3
| -0.1% | -$115 |
2013 Q2
5 quarters
|
|
5345
PUT
American Tower
AMT
$86B
| $169K | ﹤0.01% |
1,800
-1,000
| -36% | -$95.2K |
2013 Q2
5 quarters
|
|
5346
Grupo Aeroportuario del Sureste
ASR
$7.47B
| $169K | ﹤0.01% |
1,316
-1,275
| -49% | -$163K |
2013 Q2
5 quarters
|
|
5347
UBS Asset Management Income Fund, Inc.
CIK
$128M
| $169K | ﹤0.01% |
49,346
-23,694
| -32% | -$84.3K |
2013 Q2
5 quarters
|
|
5348
CALL
CenterPoint Energy
CNP
$27.9B
| $169K | ﹤0.01% |
6,900
+1,900
| +38% | +$46.7K |
2013 Q2
5 quarters
|
|
5349
CALL
Cirrus Logic
CRUS
$5.69B
| $169K | ﹤0.01% |
8,100
-7,800
| -49% | -$181K |
2013 Q2
5 quarters
|
|
|
DHY
5350
UBS Asset Management High Yield Credit Fund
DHY
$228M
| $169K | ﹤0.01% |
5,471
+3
| +0.1% | +$95 |
2013 Q2
5 quarters
|
|
Similar funds
MGC
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.